...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Design of antimicrobial polycaprolactam nanocomposite by immobilizing subtilisin conjugated Au/Ag core-shell nanoparticles for biomedical applications
【24h】

Design of antimicrobial polycaprolactam nanocomposite by immobilizing subtilisin conjugated Au/Ag core-shell nanoparticles for biomedical applications

机译:固定枯草杆菌蛋白酶共轭Au / Ag核 - 壳纳米粒子进行抗菌多己酰胺纳米复合材料进行生物医学应用

获取原文
获取原文并翻译 | 示例

摘要

Preparation of the gold core and silver shell NP (AuAgNP) is challenging because of the facile oxidation of silver. Here such a NP is carefully synthesized and conjugated with subtilisin to arrive at a stable spherical material of 120-130 nm in diameter (AuAgSNP). A biomaterial prepared by immobilizing AuAgSNP on polycaprolactam (PCL) exhibits antibiofilm properties against S. aureus and E. coli, but with lesser potency than the one prepared with bare AuAgNP. Subtilisin degrades the adhesive surface proteins of the bacteria thereby preventing the biofilm formation. Subtilisin conjugated AuAgSNP is not cytotoxic to 3T3 cells at its MIC, in contrast to AuAgNP. The presence of subtilisin promotes the fibroblast proliferation. This study indicates that AuAgSNP has antibacterial/antibiofilm activities as well as biocompatibility unlike NPs which are very cytotoxic to cells. Hence AuAgSNP can be used in medical implants and devices.
机译:由于银色氧化,金芯和银壳NP(AuAGNP)的制备是具有挑战性的。 这里仔细合成这样的NP并与枯草杆菌蛋白酶缀合,以达到直径为120-130nm的稳定球形材料(AuAgsnP)。 通过固定在多己内酰胺(PCL)上的AuAgsnP制备的生物材料表现出抗Aurefilm属性和大肠杆菌的抗体,但效力小于用裸AuAgnp制备的效力。 枯草杆菌蛋白酶降解了细菌的粘合剂表面蛋白,从而防止生物膜形成。 与AuAgnP相比,枯草杆菌蛋白酶缀合的AuAgsnP不是在其MIC的3T3细胞中的细胞毒性。 枯草杆菌蛋白酶的存在促进了成纤维细胞增殖。 本研究表明,与细胞是非常细胞毒性的NPS,AuAgsnp具有抗菌/抗生素活动以及生物相容性。 因此,Auagsnp可用于医疗植入物和设备。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号